T1	intervention 14 22	exercise
T2	duration 73 81	12-month
T3	No-of-participants 593 605	Four hundred
T4	average-age 664 675	50-74â€‰years
T5	eligibility 606 658	previously inactive but healthy postmenopausal women
T6	outcome-Measure 784 797	VEGF and FGF2
T7	outcome 952 989	changes in plasma VEGF or FGF2 levels
T8	outcome 1056 1091	differences in growth factor levels
